Molecular mechanisms controlling E-cadherin expression in breast cancer.
about
Expression of DDX3 is directly modulated by hypoxia inducible factor-1 alpha in breast epithelial cellsLevels of soluble E-cadherin in breast, gastric, and colorectal cancersWAVE2 regulates epithelial morphology and cadherin isoform switching through regulation of Twist and AblExosomes secreted under hypoxia enhance invasiveness and stemness of prostate cancer cells by targeting adherens junction moleculesRegulation of epithelial-mesenchymal transition through epigenetic and post-translational modificationsMospd1, a new player in mesenchymal versus epidermal cell differentiationRestoration of E-cadherin expression by selective Cox-2 inhibition and the clinical relevance of the epithelial-to-mesenchymal transition in head and neck squamous cell carcinomaMetastatic phenotype is regulated by estrogen in thyroid cells.Epithelial-mesenchymal transition in cancer: Role of the IL-8/IL-8R axis.E-cadherin polymorphisms and breast cancer susceptibility: a report from the Shanghai Breast Cancer Study.Kruppel-like factor 4 inhibits epithelial-to-mesenchymal transition through regulation of E-cadherin gene expressionErythropoietin drives breast cancer progression by activation of its receptor EPORPromoter Methylation in Prostate Cancer and its Application for the Early Detection of Prostate Cancer Using Serum and Urine Samples.Carnosic acid inhibits the epithelial-mesenchymal transition in B16F10 melanoma cells: a possible mechanism for the inhibition of cell migration.miRNA control of tumor cell invasion and metastasis.Down-regulation of GEP100 causes increase in E-cadherin levels and inhibits pancreatic cancer cell invasion.Unmasking epithelial-mesenchymal transition in a breast cancer primary culture: a study reportInvasive Lobular Carcinomas Do Not Express Basal Cytokeratin Markers CK5/6, CK14 and CK17.A molecular computational model improves the preoperative diagnosis of thyroid nodules.Correlation between Slug transcription factor and miR-221 in MDA-MB-231 breast cancer cells.GATA1 induces epithelial-mesenchymal transition in breast cancer cells through PAK5 oncogenic signaling.Estrogen-related receptor gamma promotes mesenchymal-to-epithelial transition and suppresses breast tumor growthAbnormal expression of serum soluble E-cadherin is correlated with clinicopathological features and prognosis of breast cancer.Anti-metastatic and anti-tumor growth effects of Origanum majorana on highly metastatic human breast cancer cells: inhibition of NFκB signaling and reduction of nitric oxide production.Multicentric and multifocal versus unifocal breast cancer: differences in the expression of E-cadherin suggest differences in tumor biology.Benzyl isothiocyanate inhibits epithelial-mesenchymal transition in cultured and xenografted human breast cancer cellsCadherin-catenin complex dissociation in lobular neoplasia of the breastOTUB1 promotes metastasis and serves as a marker of poor prognosis in colorectal cancer.Survivin is a novel target of CD44-promoted breast tumor invasionAberrant promoter methylation of the CHD1 gene may contribute to the pathogenesis of breast cancer: a meta-analysis.Promoter methylation and polymorphism of E-cadherin gene may confer a risk to prostate cancer: a meta-analysis based on 22 studies.Expression of E-cadherin, N-cadherin and snail and their correlation with clinicopathological variants: an immunohistochemical study of 132 invasive ductal breast carcinomas in Egypt.Molecular characterization of the tumor-suppressive function of nischarin in breast cancer.Decorin-mediated inhibition of colorectal cancer growth and migration is associated with E-cadherin in vitro and in miceMechanobiology of tumor invasion: engineering meets oncology.The number of polyploid giant cancer cells and epithelial-mesenchymal transition-related proteins are associated with invasion and metastasis in human breast cancer.Claudin-1 expression confers resistance to anoikis in colon cancer cells in a Src-dependent mannerDoxycycline reverses epithelial-to-mesenchymal transition and suppresses the proliferation and metastasis of lung cancer cellsMicroRNA-10b targets E-cadherin and modulates breast cancer metastasis.Neutrophil Granulocytes in Ovarian Cancer - Induction of Epithelial-To-Mesenchymal-Transition and Tumor Cell Migration.
P2860
Q21135525-97CC9A56-3C6B-4FAC-A7EF-3BC95F16AAF0Q27012638-E6B795B2-CBB6-4371-A2FE-4D073CE49C43Q27318554-8A692392-ADA8-416D-98B6-F9F17171EABBQ27333594-DBC802D8-CB5E-4686-AE68-C680E2A0CEA2Q28076697-5C7CE6A7-352F-4A67-BD87-D5A200C66B82Q28594736-B91E857B-5EDA-4C96-A7A6-3374D97365EAQ33646333-DE145031-2765-406C-9478-C8D48BF11861Q33707854-0FCBCE9A-74F3-4251-9713-F3FECCBF298BQ33751266-25C98F8C-285D-4343-8E38-E58351D9C548Q33869447-B66CFB18-E6CE-4C0B-A783-41419435526FQ33883339-DDEA6EA8-5905-4C7A-8AF0-D0C256648AABQ33888764-01FE4EA6-9EE0-45F4-98F1-0C327401C11DQ34014559-0FBA2495-8653-4012-A01E-BCB6B7A6D3C6Q34072491-6F46E2E6-471A-4D1E-928C-B56AD502D7AFQ34179359-FD0C2491-195E-4B7A-B4F6-5D6D9F4ADB4DQ34291356-BC9E0C1F-6D02-4B95-991A-C6F862DE3869Q34324979-89695F78-B1F8-4AC9-831E-3D27D17D209DQ34392810-79200822-C745-4EDD-82A1-C4192254D227Q34408933-26E7F33C-DD14-4286-9CEF-F69C33ADC258Q34432552-F5FE5952-FC50-4359-875C-29EA28191EECQ34465040-CB619CDB-59AC-4FDE-A772-CA90675D337DQ34762100-45EBF737-0A66-4121-8389-3702A1BD8BDAQ34789523-3E27DB0B-A0A4-40D4-9934-B48934963906Q34851241-B4874E4A-E192-45AF-BAA8-97536DB8C6CBQ34868613-59B508D1-A3C0-4D5B-A7D8-EC8F6709EEEDQ35091219-11F2CC80-2101-43CB-968B-4FC890A4A8E7Q35146526-A072F43B-56A7-43F1-AB8E-E42611F3E5B0Q35154448-02D03A7C-D375-4AF9-861A-550E4B9A4592Q35168013-AE9F1536-C6BB-45BF-9A11-66F35E6660EDQ35192802-E268C154-329A-497C-90C6-41475DFE8407Q35212069-A10DBB48-FEF7-49BA-A1FD-8C6D554A58A8Q35232419-5458FD47-86B8-4958-B5DB-1865A594FDE6Q35383627-DC068670-385D-4FAC-887E-387C149AEC49Q35730719-1F2EED48-0588-4228-A763-4EA5A6F3FE5EQ35877893-4401C8CA-5659-4AB3-961C-7DEAD77B3305Q36402074-33C98CFB-0E74-4BC4-8820-F35BAC2ADEA1Q36435764-D3AF31D2-BC96-4CD5-9588-4C460B3BACBBQ36562128-D9F1A2CF-F0CB-4AD5-99DA-25B9FDD7FF6BQ36577259-483C5E7F-9B2F-4665-91DE-10F8AF0D495BQ36764923-7BB638A2-DEDA-4F8E-8339-57730A45410D
P2860
Molecular mechanisms controlling E-cadherin expression in breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 18 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Molecular mechanisms controlling E-cadherin expression in breast cancer.
@en
Molecular mechanisms controlling E-cadherin expression in breast cancer.
@nl
type
label
Molecular mechanisms controlling E-cadherin expression in breast cancer.
@en
Molecular mechanisms controlling E-cadherin expression in breast cancer.
@nl
prefLabel
Molecular mechanisms controlling E-cadherin expression in breast cancer.
@en
Molecular mechanisms controlling E-cadherin expression in breast cancer.
@nl
P2860
P1476
Molecular mechanisms controlling E-cadherin expression in breast cancer.
@en
P2093
Somesh Baranwal
Suresh K Alahari
P2860
P356
10.1016/J.BBRC.2009.04.051
P407
P577
2009-04-18T00:00:00Z